Bengaluru: Aster International Institute of Oncology (AIIO), Aster Whitefield Hospital, Bengaluru to implement intra-operative electron radiation therapy (IOeRT). The new state-of-the-art medical facility is a centre of excellence for comprehensive cancer care, specialising in cutting-edge treatments and robotic surgery.
IOeRT – an innovative form of radiotherapy, delivers concentrated radiation directly to the tumour site during surgery, reducing the need for multiple post-operative radiation sessions and protecting surrounding healthy tissues from unnecessary exposure. By targeting any remaining microscopic cancer cells immediately after tumour removal, this therapy not only increases the chances of successful treatment but also improves patient outcomes and recovery times. Backed by a team of skilled surgeons, radiation oncologists, and support staff, the hospital provides a personalised, patient-centered approach that integrates the latest medical advancements with compassionate care.
Alisha Moopen, Deputy Managing Director, Aster DM Healthcare, said, “With the integration of this advanced technology, our hospital is stepping into a new frontier of precision oncology, offering treatments that are more targeted, effective, and less invasive thus enabling faster recovery for patients. We aim to set new benchmarks for treatment protocols, ensuring that patients have access to the most sophisticated tools and techniques available globally. By integrating cutting-edge innovations, we strive to not only enhance the quality of treatment for our patients but also reduce recovery time enabling a quicker return to normal life for our patients. We believe that the future of healthcare lies in combining precision, efficiency, and patient comfort, and we are dedicated to leading that transformation.”Dr Somashekhar SP, Global Director- Aster International Institute of Oncology, Chairman – Medical Advisor Board, Aster DM Healthcare, said, “With IOeRT, we can offer new hope to patients facing complex and advanced cancers, where conventional treatments often fall short. The precision of this technology allows us to target residual cancer cells with unparalleled accuracy, leading to fewer side effects and a better chance of recovery. This breakthrough is set to significantly impact cancer care, reducing recurrence rates and improving long-term outcomes.”
As India braces for a projected 57.5 per cent increase in cancer cases by 2040, according to the GLOBOCAN report, IOeRT offers a critical solution to address the growing burden of cancer. It is particularly effective in treating complex cancers such as breast, gastrointestinal, and lung cancer, where precision and early intervention are key to successful treatment.
Dr MS Beliappa, HOD and Lead Consultant – Radiation Oncology, Aster Hospitals, Bangalore, remarked,“We are bringing the next-generation IOeRT advancement in cancer treatment, offering unparalleled precision in delivering high-dose radiation. This technology not only enhances treatment outcomes but also allows patients to experience faster recovery with fewer side effects, revolutionising how we approach cancer care in India.”
Dr Felipe Calvo, Co- Director, Department of Radiation Oncology, Cancer Centre Clinica Universidad de Navarra (Madrid), said, “The adoption of IOeRT in India represents a major leap in cancer care. This technology, which has proven highly effective in Europe, is now set to transform outcomes for Indian patients. By delivering targeted radiation during surgery, IOeRT reduces the risk of recurrence and significantly improves the quality of life for those facing difficult-to-treat cancers.”
Francesco Zanetti, President & CEO, SIT, expressed, “This precision-focused equipment will empower oncologists in India to offer more effective, personalised treatments, ultimately improving survival rates and quality of care.”
